Using the CRISP-Cas system, Bester et al. recently identified the lncRNA GAS6-As2 as the main regulator of the GAS6/TAM pathway in a panel of tumor cell lines; over-activation of this pathway leads to resistance in multiple cancer types, including CRC [100]. This evidence concerns the gene GAS6 and neoplasm.